3rd Asian-Pacific Congress of Hypertension
Singapore, 3rd
April - 7th April 2004
|
|
|
|
Foreword
Hypertension is a world wide problem and a leading risk factor for
cardiovascular disease.
The criteria for normal BP and hypertension have changed considerably
over the last three decades and the guidelines for antihypertensive
therapy continue to evolve as new clinical trial evidence emerge
The prevalence of hypertension varies in different parts of the Asia
Pacific region but in all countries effective control of hypertension is
a major problem.The theme of the 3rd Asian Pacific Congress of
Hypertension “Achieving Targets in Hypertension Control” focuses on and
the scientific proceedings examine different aspects of this problem and
the challenge to develop effective strategies to deal with it.
They also reflect the multidisciplinary nature of hypertension as the
participants come from different specialties from cardiologists to
nephrologists to endocrinologist to neurologists and other medical
practitioners
The Organising Committee of the 3rd Asian Pacific Congress of
Hypertension welcomes all participants to this meeting in Singapore and
wishes all a productive and an enjoyable experience
Dr. Low Lip Ping
INDEX
Invited Lectures
Which Guidelines is Best - JNC VII, ESH–ESC, or WHO-ISH?
R.F. Abarquez, Jr.
How to Protect Against Death at Dawn
E. Cabral
The New Genetics in Hypertension: Asia Pacific Perspective
D. Gu and D. Ge
Should Clinic or 24hr Ambulatory BP Monitoring Guide Physicians?
A. Stanton and E. O’Brien
Hypertension Treatment Targets: Hypertension in People with Diabetes
C.F. Sum
Hypertensive Treatment in Pregnant Women
J. Whitworth
Anti-hypertensive Drug Treatment in Diabetes and Renal Disease
J. Whitworth
Hypertension In Children and Adolescents
H.K. Yap
Free Papers
Homocysteine Levels in Malaysian Hypertensive Subjects: Essential Analysis
A. Azizi, O.H. Kasule and A.R. Tariq
Knowledge of Paramedical Students on Hypertension
T. Guru Vythiaganapathy, R. Kashyap, K. Priya, M. Chokkalingam and P.
Thirumalai Kolundusubramanian
Differentiate Two Different Cardiac Hypertrophy by Pulse Tissue Doppler
Imaging: Hypertensive and Athletic
E. Kasikcioglu, H. Akhan, H. Oflaz and A. Kayserilioglu
Repolarization Heterogeneity During Strenous Exercise in Hypertensive
Patients and Strenght-trained Athletes
E. Kasikcioglu, H. Oflaz, H. Akhan and A. Kayserilioglu
Hypertension in Rural Area of Nepal
R. Koju, S. Dangol, A. Sharma and B. Karmacharya
Changes in Renal Medullary Blood Flow in Obese Zucker Rats
K. Nakanishi
Renoprotective Effect of Olmesartan (OLM), a Novel AT1 Receptor Blocker and
Captopril (CAP) on Dysfunction of the Glomerular Basement Membrane (GBM) of
Spontaneously Hypertensive Rats (SHR) with STZ-induced Diabetes
S. Onuma, K. Nakanishi, R. Iwasa and G. Yoshino
Post Marketing Surveillance of Losartan and Ramipril Combination (Loram) in
Hypertensive Patients
D. Pawar and M. Yeolekar
The Relationship between Serum Aldosterone and Left Ventricular Geometry or
Diastolic Function in Essential Hypertension
J. Shin, J. Lee, K.S. Kim, S.G. Kim, J.H. Kim,
H.K. Lim and B.H. Lee
Association Between Primary Hypertension in Ethnic Chinese Singaporeans and
Haplotypes of Beta2 Adrenergic Receptor Gene
L.K. Sng, Y.W. Lee, E.A. Taylor, H.M. Wu,
E.P.H. Yap and V.M.S. Oh
Advertisements on Antihypertensive Agents in Indian Medical Journals
P. Thirumalaikolundusubramanian, S. Hiteshvara,
M.P. Narmadha, A. Thomas and M. Nagarajan
Digitized QT Dispersion by the Valsalva Maneuver in Hypertensive Patients
H.-J. Yoon |